Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Yukie Omori"'
Autor:
Yukie, Omori, Satoshi, Osaga, Hirokazu, Shiheido, Naoko, Toriguchi, Chihiro, Iseki, Hiroko, Bando
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 49(10)
The purpose of this study was to investigate adherence to adjuvant endocrine therapy (ET) and the factors affecting demotivation and motivation to continue adjuvant ET. In patients with hormone receptor-positive breast cancer in Japan, an online surv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::37a081c6e287c762039becd53a301ba9
https://pubmed.ncbi.nlm.nih.gov/36281599
https://pubmed.ncbi.nlm.nih.gov/36281599
Autor:
Keunchil Park, Yukie Omori, Sotaro Enatsu, Alan Brnabic, Akira Inoue, Narayan Rajan, Joo Hang Kim, Jin-Yuan Shih
Publikováno v:
Haigan. 59:1140-1150
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c48699f5b0e9dde6a14e2be769fba177
https://doi.org/10.2482/haigan.59.1140
https://doi.org/10.2482/haigan.59.1140
Publikováno v:
Breast Cancer (Tokyo, Japan)
Background This study aimed to identify factors affecting patients’ preferences for postmenopausal hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2−) advanced breast cancer treatments, their relative import
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d3a3461c42fb9e9ea52a90192b974f5
https://pubmed.ncbi.nlm.nih.gov/30949915
https://pubmed.ncbi.nlm.nih.gov/30949915
Autor:
Yukie, Omori, Sotaro, Enatsu
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 45(11)
Pemetrexed(Alimta®)is a multi-targeted antifolate that shows antitumor effects by inhibiting enzymes in the folate metabolic pathway essential for cell replication. Pemetrexed is a standard treatment for Japanese patients with nonsquamous, non-small
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8f391e8715a14b5c119ba672e315a817
https://pubmed.ncbi.nlm.nih.gov/30449848
https://pubmed.ncbi.nlm.nih.gov/30449848
Autor:
Kazuhiko Yamada, Hiroshi Sakai, Yuichi Takiguchi, Katsuyuki Hotta, Toshiaki Takahashi, Yuichiro Ohe, Makoto Nishio, Keisuke Tomii, Yukie Omori, Ami Kamada, Terufumi Kato, Kazuhiko Nakagawa, Yukio Hosomi, Nobuyuki Yamamoto, Kazumi Suzukawa, Shunichi Sugawara, Hiroshige Yoshioka, Satoshi Watanabe, Mitsuhiro Takenoyama, Seiji Niho, Tomohide Tamura, Sotaro Enatsu
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 129
This open-label, multicenter, phase 1b/2 study assessed necitumumab plus gemcitabine and cisplatin (GC + N) in patients with previously untreated squamous non-small cell lung cancer in Japan.The phase 1b part determined the gemcitabine dose for the p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf0663d3f33e33e0d4030c2bbc97560f
https://pubmed.ncbi.nlm.nih.gov/31014853
https://pubmed.ncbi.nlm.nih.gov/31014853
Autor:
Keisuke Tomii, Yuichiro Ohe, Makoto Nishio, Satoshi Watanabe, Hiroshi Sakai, Kazuhiko Yamada, Toshiaki Takahashi, Yukie Omori, Katsuyuki Hotta, Yuichi Takiguchi, Terufumi Kato, Kazuhiko Nakagawa, Ami Kamada, Tomohide Tamura, Nobuyuki Yamamoto, Hiroshige Yoshioka, Yukio Hosomi, Kazumi Suzukawa, Shunichi Sugawara, Mitsuhiro Takenoyama, Seiji Niho, Sotaro Enatsu
Publikováno v:
Lung Cancer. 132:157-158
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9a475ec893b69f55b34020ced93ce608
https://doi.org/10.1016/j.lungcan.2019.04.010
https://doi.org/10.1016/j.lungcan.2019.04.010
Publikováno v:
Journal of Thoracic Oncology. 13:S693
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c4948b80786bd00511379fd71115cdcf
https://doi.org/10.1016/j.jtho.2018.08.1128
https://doi.org/10.1016/j.jtho.2018.08.1128
Autor:
Carla Visseren-Grul, Yukie Omori, Kazuhiko Nakagawa, K. Suzukawa, Makoto Nishio, Kazuto Nishio, Sotaro Enatsu
Publikováno v:
Journal of Thoracic Oncology. 13:S896
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::37b357a1ea3596a151a7711de51ec4d9
https://doi.org/10.1016/j.jtho.2018.08.1635
https://doi.org/10.1016/j.jtho.2018.08.1635
Autor:
Yuichiro Ohe, Satoshi Watanabe, Makoto Nishio, Yukio Hosomi, Kazumi Suzukawa, Shunichi Sugawara, Hiroshi Sakai, Tomohide Tamura, Katsuyuki Hotta, Nobuyuki Yamamoto, Yukie Omori, Mitsuhiro Takenoyama, Kazuhiko Yamada, Kazuhiko Nakagawa, Seiji Niho, Keisuke Tomii, Hiroshige Yoshioka, Ami Kamada, Yuichi Takiguchi, Sotaro Enatsu
Publikováno v:
Journal of Clinical Oncology. 36:9038-9038
9038Background: A randomized global phase III trial (SQUIRE) demonstrated statistically significant improvement in OS and PFS for GC+N versus GC in patients (pts) with advanced SqCLC. Methods: Phas...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::355e2caccb6657c86f043b97927474eb
https://doi.org/10.1200/jco.2018.36.15_suppl.9038
https://doi.org/10.1200/jco.2018.36.15_suppl.9038
Publikováno v:
Journal of Thoracic Oncology. 12:S901
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f6bd6e5fe8ae7040c6a5ccec6467b9fb
https://doi.org/10.1016/j.jtho.2016.11.1231
https://doi.org/10.1016/j.jtho.2016.11.1231